Status:
COMPLETED
Ultrafiltration on Coagulation Performance in Cardiac Surgery
Lead Sponsor:
Konkuk University Medical Center
Conditions:
Cardiac Valve Disease
Eligibility:
All Genders
19+ years
Brief Summary
In cardiac surgery patients with CPB-induced dilutional coagulopathy, ultrafiltration (UF) was applied to reduce free water and concentrate all blood components before the weaning from CPB. The impact...
Detailed Description
In cardiac surgery patients, ultrafiltration (UF) was applied to reduce free water and concentrate all blood components during cardiopulmonary bypass (CPB). Concentrating plasma substrate of UF would ...
Eligibility Criteria
Inclusion
- Patients underwent cardiac surgery during Jan 2019-Dec 2021
- Patients underwent moderate hypothermic CPB
- Patients underwent ultrafiltration during CPB
- Patients underwent ROTEM tests (EXTEM assays and FIBTEM assay) before and after applying ultrafiltration
Exclusion
- Patients underwent packed RBC transfusion \> 3 units during CPB
- patients underwent ultrafiltration but the removed free water was \< 250 ml
- Patients underwent deep hypothermia
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05252559
Start Date
August 1 2021
End Date
June 1 2022
Last Update
June 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Konkuk University Medical Center
Seoul, South Korea, 05030